No Data
No Data
Investors in Actinogen Medical (ASX:ACW) Have Unfortunately Lost 76% Over the Last Three Years
Actinogen Medical Doses First Participant in Alzheimer's Disease Trial in US; Shares Rise Nearly 7%
This Biotech Stock Raised $11M in a Risk-off Environment. Its Alzheimer's Drug Could Change the Game
Actinogen Receives $9M R&D Tax Rebate to Fund Alzheimer's Trial
Actinogen Medical Ltd: Actinogen receives $9.0 million R&D tax incentive rebate
Actinogen Medical Ltd: Annual Report to Shareholders
151479178 : What are you talking about